A team found that CD69+CD103-CD8+ Trm was enriched when hepatic fibrosis subsides in NASH mouse, and confirmed that CD8+ Trm could attract HSCs and mediate apoptosis through Fas/FasL pathway, leading to the resolution of hepatic fibrosis [41]. Here, CD8A is linked to metabolic dysfunction-associated steatohepatitis.